• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用非参数贝叶斯方法对SF-6D健康状态偏好数据进行建模。

Modelling SF-6D health state preference data using a nonparametric Bayesian method.

作者信息

Kharroubi Samer A, Brazier John E, Roberts Jennifer, O'Hagan Anthony

机构信息

Department of Mathematics, University of York, Heslington, York YO10 5DD, UK.

出版信息

J Health Econ. 2007 May 1;26(3):597-612. doi: 10.1016/j.jhealeco.2006.09.002. Epub 2006 Oct 27.

DOI:10.1016/j.jhealeco.2006.09.002
PMID:17069909
Abstract

This paper reports on the findings from applying a new approach to modelling health state valuation data. The approach applies a nonparametric model to estimate SF-6D health state utility values using Bayesian methods. The data set is the UK SF-6D valuation study where a sample of 249 states defined by the SF-6D (a derivative of the SF-36) was valued by a representative sample of the UK general population using standard gamble. The paper presents the results from applying the nonparametric model and comparing it to the original model estimated using a conventional parametric random effects model. The two models are compared theoretically and in terms of empirical performance. The paper discusses the implications of these results for future applications of the SF-6D and further work in this field.

摘要

本文报告了应用一种新方法对健康状态评估数据进行建模的研究结果。该方法应用非参数模型,通过贝叶斯方法估计SF-6D健康状态效用值。数据集为英国SF-6D评估研究,其中由SF-6D(SF-36的衍生版本)定义的249种状态样本,由英国普通人群的代表性样本采用标准博弈法进行了评估。本文展示了应用非参数模型的结果,并将其与使用传统参数随机效应模型估计的原始模型进行了比较。从理论和实证表现方面对这两种模型进行了比较。本文讨论了这些结果对SF-6D未来应用以及该领域进一步研究工作的启示。

相似文献

1
Modelling SF-6D health state preference data using a nonparametric Bayesian method.使用非参数贝叶斯方法对SF-6D健康状态偏好数据进行建模。
J Health Econ. 2007 May 1;26(3):597-612. doi: 10.1016/j.jhealeco.2006.09.002. Epub 2006 Oct 27.
2
A comparison of Hong Kong and United Kingdom SF-6D health states valuations using a nonparametric Bayesian method.使用非参数贝叶斯方法对香港和英国 SF-6D 健康状态估值进行比较。
Value Health. 2014 Jun;17(4):397-405. doi: 10.1016/j.jval.2014.02.011. Epub 2014 May 10.
3
Modelling covariates for the SF-6D standard gamble health state preference data using a nonparametric Bayesian method.使用非参数贝叶斯方法对SF-6D标准博弈健康状态偏好数据的协变量进行建模。
Soc Sci Med. 2007 Mar;64(6):1242-52. doi: 10.1016/j.socscimed.2006.10.040. Epub 2006 Dec 8.
4
Modeling SF-6D Hong Kong standard gamble health state preference data using a nonparametric Bayesian method.采用非参数贝叶斯方法对 SF-6D 香港标准博弈健康状态偏好数据进行建模。
Value Health. 2013 Sep-Oct;16(6):1032-45. doi: 10.1016/j.jval.2013.06.020.
5
Use of Bayesian methods to model the SF-6D health state preference based data.贝叶斯方法在 SF-6D 健康状态偏好模型中的应用。
Health Qual Life Outcomes. 2018 Dec 18;16(1):234. doi: 10.1186/s12955-018-1068-7.
6
A Bayesian Nonparametric Approach for Modeling SF-6D Health State Utility Scores.贝叶斯非参数方法在 SF-6D 健康状态效用评分模型中的应用。
Value Health Reg Issues. 2022 Jan-Feb;27:1-11. doi: 10.1016/j.vhri.2021.02.004. Epub 2021 Nov 13.
7
Estimating a preference-based index from the Japanese SF-36.从日本 SF-36 中估算偏好为基础的指标。
J Clin Epidemiol. 2009 Dec;62(12):1323-31. doi: 10.1016/j.jclinepi.2009.01.022. Epub 2009 Jul 16.
8
Modeling HUI 2 health state preference data using a nonparametric Bayesian method.使用非参数贝叶斯方法对健康效用指数2(HUI 2)健康状态偏好数据进行建模。
Med Decis Making. 2008 Nov-Dec;28(6):875-87. doi: 10.1177/0272989X08318460. Epub 2008 Oct 29.
9
Estimating the SF-6D value set for a population-based sample of Brazilians.估算基于巴西人群的 SF-6D 值集。
Value Health. 2011 Jul-Aug;14(5 Suppl 1):S108-14. doi: 10.1016/j.jval.2011.05.012.
10
Valuation of preference-based measures: can existing preference data be used to generate better estimates?基于偏好的衡量指标的评估:现有的偏好数据是否可以用来生成更好的估计值?
Health Qual Life Outcomes. 2018 Jun 5;16(1):116. doi: 10.1186/s12955-018-0945-4.

引用本文的文献

1
Assessments of Health Utilities in Patients With Metabolic Dysfunction-Associated Steatohepatitis: Cross-Walk Between Disease-Specific Chronic Liver Disease Questionnaire, Short Form SF-6D, and EuroQol EQ-5D Instruments.代谢功能障碍相关脂肪性肝炎患者的健康效用评估:特定疾病慢性肝病问卷、简版SF-6D和欧洲五维健康量表(EQ-5D)之间的交叉对照
Gastro Hep Adv. 2025 Feb 7;4(6):100642. doi: 10.1016/j.gastha.2025.100642. eCollection 2025.
2
Analysis of Cost and Treatment Effects in the Care Given for Graves' Disease: A Swedish Cost-Utility Analysis.格雷夫斯病治疗的成本与治疗效果分析:一项瑞典成本效用分析
Endocrinol Diabetes Metab. 2025 Mar;8(2):e70034. doi: 10.1002/edm2.70034.
3
The Short Form 6 Dimensions (SF-6D): Development and Evolution.
简短健康调查问卷6维度量表(SF-6D):发展与演变
Appl Health Econ Health Policy. 2025 Jan;23(1):19-33. doi: 10.1007/s40258-024-00919-8. Epub 2024 Oct 26.
4
The Correlation Between Body Mass Index and Health-Related Quality of Life: Data from Two Weight Loss Intervention Studies.体重指数与健康相关生活质量的相关性:来自两项减肥干预研究的数据。
Adv Ther. 2024 Nov;41(11):4228-4247. doi: 10.1007/s12325-024-02932-8. Epub 2024 Sep 24.
5
Quality-adjusted life years and surgical waiting list: Systematic review of the literature.质量调整生命年与手术等候名单:文献系统综述
World J Gastrointest Surg. 2024 Apr 27;16(4):1155-1164. doi: 10.4240/wjgs.v16.i4.1155.
6
Factors influencing medical expenditures in patients with unresolved facial palsy and pharmacoeconomic analysis of upper eyelid lid loading with gold and platinum weights compared to tarsorrhaphy.影响未解决面神经麻痹患者医疗费用的因素以及与睑裂缝合术相比,使用金和铂重量的上睑负重的药物经济学分析。
Health Econ Rev. 2024 Apr 27;14(1):30. doi: 10.1186/s13561-024-00506-6.
7
Assessing health-related quality of life of Chinese population using CQ-11D.使用 CQ-11D 评估中国人群的健康相关生命质量。
Health Qual Life Outcomes. 2024 Apr 19;22(1):34. doi: 10.1186/s12955-024-02250-1.
8
The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities.澳大利亚成年人心理困扰的隐性代价及其对健康相关生活质量(以健康状态效用衡量)的影响。
Appl Health Econ Health Policy. 2024 Jul;22(4):583-598. doi: 10.1007/s40258-024-00879-z. Epub 2024 Mar 26.
9
Mapping the World Health Organization Disability Assessment Schedule (WHODAS 2.0) onto SF-6D Using Swedish General Population Data.利用瑞典普通人群数据将世界卫生组织残疾评定量表(WHODAS 2.0)映射到SF-6D上。
Pharmacoecon Open. 2023 Sep;7(5):765-776. doi: 10.1007/s41669-023-00425-y. Epub 2023 Jun 15.
10
Implementation of the Management of Anticoagulation in the Periprocedural Period App into an Electronic Health Record: A Cost-Effectiveness Analysis.在电子病历中实施围手术期抗凝管理 App:成本效益分析。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231154553. doi: 10.1177/10760296231154553.